PN6047 demonstrates preclinical efficacy in headache models as a novel delta-opioid receptor agonist.
- DOI
- 10.1186/s10194-026-02473-1
- Published
- 2026 Aug 6
- Container
- The journal of headache and pain
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s10194-026-02473-1,
title = {PN6047 demonstrates preclinical efficacy in headache models as a novel delta-opioid receptor agonist.},
author = {Awad-Igbaria Y and Zhang Y and Aframian M and Faas GC and Charles A and Baca SM and Jutkiewicz E and von Mentzer B and Traynor J and Kendall D and Pradhan AA},
year = {2026},
journal = {The journal of headache and pain},
doi = {10.1186/s10194-026-02473-1},
url = {https://doi.org/10.1186/s10194-026-02473-1}
}RIS
TY - JOUR TI - PN6047 demonstrates preclinical efficacy in headache models as a novel delta-opioid receptor agonist. AU - Awad-Igbaria Y AU - Zhang Y AU - Aframian M AU - Faas GC AU - Charles A AU - Baca SM AU - Jutkiewicz E AU - von Mentzer B AU - Traynor J AU - Kendall D AU - Pradhan AA PY - 2026 JO - The journal of headache and pain DO - 10.1186/s10194-026-02473-1 UR - https://doi.org/10.1186/s10194-026-02473-1 ER -
APA
Y, A., Y, Z., M, A., GC, F., A, C., SM, B., E, J., B, V. M., J, T., D, K., & AA, P. (2026). PN6047 demonstrates preclinical efficacy in headache models as a novel delta-opioid receptor agonist.. The journal of headache and pain. https://doi.org/10.1186/s10194-026-02473-1
Source records
- pubmed · retrieved 2026-11-10T12:21:13.285Z